sirolimus has been researched along with plerixafor* in 2 studies
2 other study(ies) available for sirolimus and plerixafor
| Article | Year |
|---|---|
CXCR4 blockade reduces the severity of murine heart allograft rejection by plasmacytoid dendritic cell-mediated immune regulation.
Allograft-specific regulatory T cells (T Topics: Allografts; Animals; Benzylamines; Biomarkers; Cyclams; Dendritic Cells; Disease Models, Animal; Drug Synergism; Graft Rejection; Graft Survival; Heart Transplantation; Immunomodulation; Mice; Prognosis; Receptors, CXCR4; Sirolimus; T-Lymphocytes, Regulatory; Transplantation Immunology; Treatment Outcome | 2021 |
New Drugs2010, PART 1.
Topics: Acetamides; Antibodies, Monoclonal; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Azepines; Benzazepines; Benzhydryl Compounds; Benzyl Alcohol; Benzylamines; Cyclams; Cyclopropanes; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Everolimus; Febuxostat; Fluorenes; Fluoroquinolones; Gout Suppressants; Heterocyclic Compounds; Humans; Immunosuppressive Agents; Indoles; Lacosamide; Milnacipran; Oligopeptides; Phenols; Selective Serotonin Reuptake Inhibitors; Sirolimus; Tapentadol; Thiazoles; Tolvaptan; Triazoles | 2010 |